Plerixafor octahydrochloride
AMD 3100 octahydrochloride blocks the binding of stromal cell-derived factor (SDF-1alpha) to the cellular receptor CXCR4, resulting in hematopoietic stem cell (HSC) release from bone marrow and HSC movement into the peripheral circulation. Plerixafor is a bicyclam with hematopoietic stem cell-mobilizing activity.
| Catalog Number | T1776L |
| Alternative Name(s) | JM3100 octahydrochloride , Plerixafor 8HCl (AMD3100 8HCl) , Plerixafor 8HCl , SID791 octahydrochloride , AMD 3100 octahydrochloride , JM 3100 8HCl |
| Research Area | GPCR/G Protein|||Autophagy|||Proteases/Proteasome|||Microbiology/Virology|||Immunology/Inflammation |
| Molecular Formula | C28H62Cl8N8 |
| CAS# | 155148-31-5 |
| SMILES | Cl.Cl.Cl.Cl.Cl.Cl.Cl.Cl.C(N1CCCNCCNCCCNCC1)c1ccc(CN2CCCNCCNCCCNCC2)cc1 |
| Size | 50 mg |
| Supplier Page | https://www.targetmol.com/compound/Plerixafor octahydrochloride |
| Additional Information | https://www.targetmol.com/datasheet/T1776L |
